Accessibility Menu
 
Genprex logo

Genprex

(NASDAQ) GNPX

Current Price$1.53
Market Cap$13.93M
Since IPO (2018)-100%
5 Year-100%
1 Year-90%
1 Month-23%

Genprex Financials at a Glance

Market Cap

$13.93M

Revenue (TTM)

$0.00

Net Income (TTM)

$16.23M

EPS (TTM)

$-27.60

P/E Ratio

-0.06

Dividend

$0.00

Beta (Volatility)

1.23 (Average)

Price

$1.53

Volume

397,772.844

Open

$1.50

Previous Close

$1.54

Daily Range

$1.43 - $1.57

52-Week Range

$1.43 - $55.00

GNPX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genprex

Industry

Biotechnology

Employees

13

CEO

Ryan M. Confer

Headquarters

Austin, TX 78746, US

GNPX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-339%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-16.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.93M

Shares Outstanding

9.04M

Volume

397.77K

Short Interest

0.00%

Avg. Volume

1.03M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$15.52M

EBITDA

$15.49M

Operating Cash Flow

$15.31M

Capital Expenditure

$0.00

Free Cash Flow

$15.31M

Cash & ST Invst.

$7.83M

Total Debt

$0.00

Genprex Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$13.93M

N/A

Market Cap/Employee

$928.61K

N/A

Employees

15

N/A

Net Income

$3.79M

+12.5%

EBITDA

$12.45M

+387.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$7.83M

+388.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.60%

N/A

Return on Invested Capital

-1.94%

N/A

Free Cash Flow

$4.10M

-5.9%

Operating Cash Flow

$4.10M

-5.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIVIBioVie Inc.
$1.42+2.90%
CMMBChemomab Therapeutics Ltd.
$1.56-1.89%
TOVXTheriva Biologics, Inc.
$0.23+1.46%
LIMNLiminatus Pharma, Inc. Class A Common Stock
$0.17+2.34%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
NVDANvidia
$177.39+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About GNPX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.